Introduction to the special issue on stress, emotional behavior, and the endocannabinoid system: A decade of research

Neuroscience

Volumn 204, Issue , 2012, Pages 1-4

  Hill, M N ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID;

ACUTE STRESS; ANXIETY; BRAIN ELECTROPHYSIOLOGY; CHRONIC STRESS; COGNITION; DEPRESSION; EDITORIAL; EMOTIONAL STRESS; EMOTIONALITY; ENVIRONMENTAL STRESS; FACIAL EXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; BEHAVIOR, ANIMAL; EMOTIONS; ENDOCANNABINOIDS; HUMANS; STRESS, PSYCHOLOGICAL;

EID: 84857135280     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.01.038     Document Type: Editorial

References (41)

1. Atsak P., Roozendaal B., Campolongo P. Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences. Neuroscience 2012, 204:104-116.
2. Bowles N.P., Hill M.N., Bhagat S.M., Karatsoreos I.N., Hillard C.J., McEwen B.S. Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice. Neuroscience 2012, 204:83-89.
3. Campolongo P., Roozendaal B., Trezza V., Hauer D., Schelling G., McGaugh J.L., Cuomo V. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci U S A 2009, 106:4888-4893.
4. Coddington E., Lewis C., Rose J.D., Moore F.L. Endocannabinoids mediate the effects of acute stress and corticosterone on sex behavior. Endocrinology 2007, 148:493-500.
5. Crosby K.M., Bains J.S. The intricate link between glucocorticoid and endocannabinoids at stress-relevant synapses in the hypothalamus. Neuroscience 2012, 204:31-37.
6. Devane W.A., Dysarz F.A., Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988, 34:605-613.
7. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
8. Di Marzo V., Fonatana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372:686-691.
9. Di S., Malcher-Lopes R., Halmos K.C., Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 2003, 23:4850-4857.
10. Dubreucq S., Kambire S., Conforzi M., Metna-Laurent M., Cannich A., Soria-Gomez E., Richard E., Marsicano G., Chaouloff F. Cannabinoid type 1 receptors located on single-minded 1-expressing neurons control emotional behaviors. Neuroscience 2012, 204:64-73.
11. Haller J., Bakos N., Szirmay M., Ledent C., Freund T.F. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci 2002, 16:1395-1398.
12. Haring M., Guggenhuber S., Lutz B. Neuronal populations mediating the effect of endocannabinoids on stress and emotionality. Neuroscience 2012, 204:145-158.
13. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 1990, 87:1932-1936.
14. Hill M.N., Patel S., Carrier E.J., Rademacher D.J., Ormerod B.K., Hillard C.J., Gorzalka B.B. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 2005, 30:508-515.
15. Hill M.N., Tasker J.G. Endocannabinoid signaling, glucocorticoid-mediated negative feedback and regulation of the HPA axis. Neuroscience 2012, 204:38-52.
16. Hillard C.J., Weinlander K.M., Stuhr K.L. Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience 2012, 204:207-229.
17. Hohmann A.G., Suplita R.L., Bolton N.M., Neely M.H., Fegley D., Mangieri R., Krey J.F., Walker J.M., Holmes P.V., Crystal J.D., Duranti A., Tontini A., Mor M., Tarzia G., Piomelli D. An endocannabinoid mechanism for stress-induced analgesia. Nature 2005, 435:1108-1112.
18. Kathuria S., Gaetani S., Fegley D., Valiño F., Duranti A., Tontini A., Mor M., Tarzia G., LaRana G., Caliganano A., Giustino A., Tattoli M., Palmery M., Cuomo V., Piomelli D. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 2003, 9:76-81.
19. Kerr D.M., Burke N.N., Ford G.K., Connor T.J., Harhen B., Egan L.J., Finn D.P. Pharmacological inhibition of endocannabinoid degradation the expression of inflammatory mediators in the hypothalamus following an immunological stressor. Neuroscience 2012, 204:53-63.
20. Kreitzer A.C., Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoid at excitatory synapses onto Purkinje cells. Neuron 2001, 29:717-727.
21. Kupferschmidt D.A., Newman A.E., Boonstra R., Erb S. Antagonism of cannabinoid 1 receptor reverses the anxiety-like behavior induced by central injections of corticotrophin-releasing factor and cocaine withdrawal. Neuroscience 2012, 204:125-133.
22. Lee T.T., Gorzalka B.B. Timing is everything: evidence for corticolimbic endocannabinoid mediation of interactions between maturation and the hypothalamic-pituitary-adrenal axis. Neuroscience 2012, 204:17-30.
23. Lopez-Gallardo M., Lopez-Rodriguez A.B., Llorente-Berzal A., Rollant D., Mackie K., Armario A., Nadal R., Viveros M.P. Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astroxytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion. Neuroscience 2012, 204:90-103.
24. Maejima T., Hashimoto K., Yoshida T., Aida A., Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 2001, 31:463-475.
25. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., Hermann H., Tang J., Hofmann C., Zieglgänsberger W., Di Marzo V., Lutz B. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
26. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Involvement of CB1 cannabinoid receptors in emotional behavior. Psychopharmacology 2002, 159:379-387.
27. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
28. McLaughlin R.J., Gobbi G. Cannabinoids and emotionality: a neuroanatomical perspective. Neuroscience 2012, 204:134-144.
29. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.L., Pertwee R.G., Griffin G., Bayewitch M., Barg J., Vogel Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995, 50:83-90.
30. Moreira F.A., Aguiar D.C., Terzain A.L., Guimaraes F.S., Wotjak C.T. Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety: two sides of one coin. Neuroscience 2012, 204:186-192.
31. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
32. Newsom R.J., Osterlund C., Masini C.V., Day H.E., Spencer R.L., Campeau S. Cannabinoid receptor type I antagonism significantly modulates basal and loud noise-induced neural and HPA axis responses in male Sprague-Dawley rats. Neuroscience 2012, 204:64-73.
33. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004, 145:5431-5438.
34. Ramikie T.S., Patel S. Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior and adaptations to stress. Neuroscience 2012, 204:38-52.
35. Riebe C.J., Pamplona F., Kamprath K., Wotjak C.T. Fear relief-toward a new conceptual framework and what endocannabinoids gotta do with it. Neuroscience 2012, 204:159-185.
36. Roberts C.J., Stuhr K.L., Hillard C.J. Swim stress differentially affects limbic contents of 2-arachidonoylglycerol and 2-oleoylglycerol. Neuroscience 2012, 204:74-82.
37. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995, 215:89-97.
38. Valverde O., Torrens M. CB1 receptor-deficient mice as a model of depression. Neuroscience 2012, 204:193-206.
39. Vaughn L.K., Mantsch J.R., Vranjkovic O., Stroh G., Lacourt M., Kreutter M., Hillard C.J. Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways. Neuroscience 2012, 204:117-124.
40. Wilson R.I., Nicoll R.A. Endocannabinoid signaling in the brain. Science 2002, 296:678-682.
41. Zamberletti E., Prini P., Speziali S., Gabaglio M., Solinas M., Parolaro D., Rubino T. Gender-dependent behavior and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. Neuroscience 2012, 204:245-257.